声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。2024 年,是疫苗制造商艰难的一年,新冠疫苗和 RSV 疫苗需求较 2023 年有所下降。近日,Moderna宣布将2025 年营收预期下调 10 亿美元,预计营收为 15 亿至 25 亿美元。同时,该公司正在加速推进此前宣布的成本削减计划,旨在今年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.